
- /
- Supported exchanges
- / US
- / LUNG.NASDAQ
Pulmonx Corp (LUNG NASDAQ) stock market data APIs
Pulmonx Corp Financial Data Overview
Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also offers LungTraX Platform, a cloud-based quantitative computed tomography analysis service that provides physicians with multiple products, such as LungTraX Connect to improve workup efficiency; LungTraX Detect to enable patient identification; and StratX Lung report that is designed for solution that includes information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Pulmonx Corp (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Pulmonx Corp data using free add-ons & libraries
Get Pulmonx Corp Fundamental Data
Pulmonx Corp Fundamental data includes:
- Net Revenue: 90 549 K
- EBITDA: -53 949 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-07-29
- EPS/Forecast: -0.3943
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Pulmonx Corp News

Pulmonx to Participate in September Investor Conferences
REDWOOD CITY, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today ...


U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.74%
Investing.com – U.S. stocks were lower after the close on Thursday, as losses in the Healthcare, Consumer Goods and Financials sectors led shares lower. At the close in NYSE, the Dow Jones Industri...

Pulmonx slumps as Piper Sandler downgrades despite Q2 beat
[USA Recession and Crashing Economy Concept] mphillips007 Pulmonx (NASDAQ:LUNG [https://seekingalpha.com/symbol/LUNG]) shares plunged ~41% on Thursday after the lung device maker, with its second-qua...

What's going on in today's session
Wondering how the US markets performed one hour before the close of the markets on Thursday? Discover the movers and shakers of today's session in our comprehensive analysis. [topmovers] GAINERS ...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.